{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T10:56:33Z","timestamp":1791024993222,"version":"4.1.0"},"reference-count":42,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2003,7,25]],"date-time":"2003-07-25T00:00:00Z","timestamp":1059091200000},"content-version":"vor","delay-in-days":85,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["APMIS"],"published-print":{"date-parts":[[2003,5]]},"abstract":"<jats:p>Previously we and others found that a majority of chronic fatigue syndrome (CFS) patients showed evidence of systemic mycoplasmal infections, and their blood tested positive using a polymerase chain reaction assay for at least one of the four following <jats:italic>Mycoplasma<\/jats:italic> species: <jats:italic>M. fermentans<\/jats:italic>, <jats:italic>M. hominis<\/jats:italic>, <jats:italic>M. pneumoniae<\/jats:italic> or <jats:italic>M. penetrans<\/jats:italic>. Consistent with previous results, patients in the current study (n=200) showed a high prevalence (overall 52%) of mycoplasmal infections. Using forensic polymerase chain reaction we also examined whether these same patients showed evidence of infections with <jats:italic>Chlamydia pneumoniae<\/jats:italic> (overall 7.5% positive) and\/or active human herpes virus\u20106 (HHV\u20106, overall 30.5% positive). Since the presence of one or more infections may predispose patients to other infections, we examined the prevalence of <jats:italic>C. pneumoniae<\/jats:italic> and HHV\u20106 active infections in mycoplasma\u2010positive and \u2010negative patients. Unexpectedly, we found that the incidence of <jats:italic>C. pneumoniae<\/jats:italic> or HHV\u20106 was similar in <jats:italic>Mycoplasma<\/jats:italic>\u2010positive and \u2010negative patients, and the converse was also found in active HHV\u20106\u2010positive and \u2010negative patients. Control subjects (n=100) had low rates of mycoplasmal (6%), active HHV\u20106 (9%) or chlamydial (1%) infections, and there were no co\u2010infections in control subjects. Differences in bacterial and\/or viral infections in CFS patients compared to control subjects were significant. Severity and incidence of patients' signs and symptoms were compared within the above groups. Although there was a tendency for patients with multiple infections to have more severe signs and symptoms (p&lt;0.01), the only significant differences found were in the incidence and severity of certain signs and symptoms in patients with multiple co\u2010infections of any type compared to the other groups (p&lt;0.01). There was no correlation between the type of co\u2010infection and severity of signs and symptoms. The results indicate that a large subset of CFS patients show evidence of bacterial and\/or viral infection(s), and these infections may contribute to the severity of signs and symptoms found in these patients.<\/jats:p>","DOI":"10.1034\/j.1600-0463.2003.1110504.x","type":"journal-article","created":{"date-parts":[[2003,7,26]],"date-time":"2003-07-26T10:01:51Z","timestamp":1059213711000},"page":"557-566","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Multiple co\u2010infections (<i>Mycoplasma, Chlamydia<\/i>, human herpes virus\u20106) in blood of chronic fatigue syndrome patients: association with signs and symptoms"],"prefix":"10.1111","volume":"111","author":[{"given":"G. L.","family":"NICOLSON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"GAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"HAIER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2003,7,25]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-108-3-387"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-121-12-199412150-00009"},{"key":"e_1_2_5_4_2","first-page":"172","article-title":"Mycoplasmal infections in chronic illnesses: fibromyalgia and chronic fatigue syndromes, Gulf War illness, HIV\u2010AIDS and rheumatoid arthritis","volume":"5","author":"Nicolson GL","year":"1999","journal-title":"Med Sentinel"},{"key":"e_1_2_5_5_2","first-page":"42","article-title":"Chronic infections as a common etiology for many patients with chronic fatigue syndrome, fibromyalgia syndrome and Gulf War illnesses","volume":"1","author":"Nicolson GL","year":"1998","journal-title":"Intern J Med"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00041444-200109000-00003"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1300\/J092v11n02_03"},{"key":"e_1_2_5_8_2","first-page":"92","article-title":"Diagnosis and integrative treatment of intracellular bacterial infections in chronic fatigue and fibromyalgia syndromes, Gulf War illness, rheumatoid arthritis and other chronic illnesses","volume":"1","author":"Nicolson GL","year":"2000","journal-title":"Clin Pract Alt Med"},{"key":"e_1_2_5_9_2","first-page":"266","article-title":"Diagnosis and treatment of chronic mycoplasmal infections in fibromyalgia and chronic fatigue syndromes: relationship to Gulf War illness","volume":"16","author":"Nicolson GL","year":"1998","journal-title":"Biomed Ther"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540180029029"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1086\/520239"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.2002.tb00626.x"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1574-695X.1998.tb01226.x"},{"key":"e_1_2_5_14_2","first-page":"457","article-title":"The prevalence of Mycoplasma incognitus in the peripheral blood mononuclear cells of normal controls or patients with AIDS or Chronic Fatigue Syndrome","volume":"231","author":"Huang W","year":"1998","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1006\/mcpr.1998.0186"},{"key":"e_1_2_5_16_2","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/CMR.10.3.521","article-title":"Human herpesvirus\u20106","volume":"10","author":"Braun DK","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0503.990306"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/172.5.1364"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/38.6.504"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/s100960050420"},{"key":"e_1_2_5_21_2","first-page":"15","article-title":"Examination of mycoplasmas in blood of 565 chronic illness patients by polymerase chain reaction","volume":"28","author":"Nasralla MY","year":"2000","journal-title":"Intern J Med Biol Environ"},{"key":"e_1_2_5_22_2","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1128\/aem.58.8.2606-2615.1992","article-title":"Genus\u2010 and species\u2010specific identification of mycoplasmas by 16S rRNA amplification","volume":"58","author":"Van Kuppeveld FJM","year":"1992","journal-title":"Appl Environ Microbiol"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1006\/mcpr.1996.0002"},{"key":"e_1_2_5_24_2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1128\/jcm.27.11.2492-2496.1989","article-title":"Detection of Mycoplasma pneumoniae by using the polymerase chain reaction","volume":"27","author":"Bernet C","year":"1995","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.3201\/eid0301.970103"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1300\/J092v06n03_03"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1069-417X(00)88885-8"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.1.90-93.2000"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350412"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2000-9429"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.3.581"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.158.3.9711092"},{"key":"e_1_2_5_33_2","first-page":"23","article-title":"Isolation of Mycoplasma pneumoniae from asthmatic patients","volume":"70","author":"Gil JC","year":"1993","journal-title":"Ann Allergy"},{"key":"e_1_2_5_34_2","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1128\/JCM.37.6.1721-1726.1999","article-title":"Incidence of upper respiratory tract Mycoplasma pneumoniae infections among outpatients in Rh\u00f4ne\u2010Alpes, France, during five successive winter periods","volume":"37","author":"Layani\u2010Milon MP","year":"1999","journal-title":"J Clin Microbiol"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/00313029700169135"},{"issue":"1","key":"e_1_2_5_36_2","first-page":"S309","article-title":"Mycoplasmas as cofactors in infection due to the immunodeficiency virus","volume":"17","author":"Montagnier L","year":"1993","journal-title":"Clin Infect Dis"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1300\/J092v02n04_02"},{"key":"e_1_2_5_38_2","first-page":"103","article-title":"Active HHV\u20106 infection in chronic fatigue syndrome patients from Italy: new data","volume":"6","author":"Zorsenon M","year":"1996","journal-title":"J Chronic Fatigue Syndr"},{"key":"e_1_2_5_39_2","first-page":"245","article-title":"Persistent active human herpesvirus 6 (HHV\u20106) infections in patients with chronic fatigue syndrome","volume":"2","author":"Knox K","year":"1999","journal-title":"J Chronic Fatigue Syndr"},{"key":"e_1_2_5_40_2","first-page":"103","article-title":"A chronic illness characterized by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection","volume":"116","author":"Buchwald D","year":"1992","journal-title":"Arch Intern Med"},{"key":"e_1_2_5_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(99)00079-7"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.6.2.216-223.1999"},{"key":"e_1_2_5_43_2","doi-asserted-by":"publisher","DOI":"10.1086\/313908"}],"container-title":["APMIS"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-0463.2003.1110504.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-0463.2003.1110504.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:48:57Z","timestamp":1697179737000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-0463.2003.1110504.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["10.1034\/j.1600-0463.2003.1110504.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-0463.2003.1110504.x","archive":["Portico"],"relation":{},"ISSN":["0903-4641","1600-0463"],"issn-type":[{"value":"0903-4641","type":"print"},{"value":"1600-0463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]},"assertion":[{"value":"2003-07-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}